TABLE OF CONTENTS
Volume 9, Issue 5 (October 2009)
Review
Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review
D F Carr, G Whiteley, A Alfirevic and M Pirmohamed on behalf of the FolATED study team
Pharmacogenomics J 9: 291-305; advance online publication, July 7, 2009; doi:10.1038/tpj.2009.29
Original Articles
Prevalence of CYP2C9 polymorphisms in the south of Europe
Paula Sánchez-Diz, Ana Estany-Gestal, Carmelo Aguirre, Adoración Blanco, Angel Carracedo, Luisa Ibáñez, Marianna Passiu, Lisa Provezza, Ricardo Ramos-Ruiz, Borja Ruiz, Inés Salado-Valdivieso, Eladio A Velasco and Adolfo Figueiras
Pharmacogenomics J 9: 306-310; advance online publication, April 21, 2009; doi:10.1038/tpj.2009.16
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia
B A Fijal, B J Kinon, S Kapur, V L Stauffer, R R Conley, H H Jamal, J M Kane, M M Witte and J P Houston
Pharmacogenomics J 9: 311-318; advance online publication, May 19, 2009; doi:10.1038/tpj.2009.24
Association of genotypes of the CYP3A cluster with midazolam disposition in vivo FREE
J Miao, Y Jin, R L Marunde, S Kim, S Quinney, M Radovich, L Li and S D Hall
Pharmacogenomics J 9: 319-326; advance online publication, June 9, 2009; doi:10.1038/tpj.2009.21
Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52 000 individuals
D Kaur-Knudsen, S E Bojesen and B G Nordestgaard
Pharmacogenomics J 9: 327-332; advance online publication, August 4, 2009; doi:10.1038/tpj.2009.34
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors FREE
H Landmark-Høyvik, K V Reinertsen, J H Loge, S D Fosså, A L Børresen-Dale and V Dumeaux
Pharmacogenomics J 9: 333-340; advance online publication, June 23, 2009; doi:10.1038/tpj.2009.27
Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility FREE
A L Teixeira, R Ribeiro, A Morais, F Lobo, A Fraga, F Pina, F M Calais-da-Silva, F E Calais-da-Silva and R Medeiros
Pharmacogenomics J 9: 341-346; advance online publication, June 2, 2009; doi:10.1038/tpj.2009.20
Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients FREE
D Caronia, A Patiño-García, R L Milne, M Zalacain-Díez, G Pita, M R Alonso, L T Moreno, L Sierrasesumaga-Ariznabarreta, J Benítez and A González-Neira
Pharmacogenomics J 9: 347-353; advance online publication, May 12, 2009; doi:10.1038/tpj.2009.19
